NCT03086382View on ClinicalTrials.gov

A Study to Investigate the Bioequivalence of Lacosamide Tablet (200mg) and Syrup (10mg/ml) in Healthy Chinese Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 27, 2017

Primary Completion Date

March 28, 2017

Study Completion Date

March 28, 2017

Conditions

Healthy Male Volunteers

Interventions

DRUG

Lacosamide (LCM) tablet

Treatment A: Single dose of Lacosamide (LCM) 200 mg given as 2 tablets of LCM 100 mg

DRUG

Lacosamide (LCM) syrup

Treatment B: Single dose of Lacosamide (LCM) 200 mg given as syrup

Trial Locations (1)

Unknown

Sp1001 001, Shanghai

All Listed Sponsors

lead

UCB Biopharma S.P.R.L.

INDUSTRY

NCT03086382 - A Study to Investigate the Bioequivalence of Lacosamide Tablet (200mg) and Syrup (10mg/ml) in Healthy Chinese Male Subjects | Biotech Hunter | Biotech Hunter